RxSight News

Needham: Reiterated the RxSight (RXST.US) rating, adjusted from buy to buy rating, target price $64.00.

Zhitong FinanceApr 11 18:01

RxSight Analyst Ratings

BenzingaApr 11 17:49

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), RxSight (RXST) and Clearside Biomedical (CLSD)

TipRanksApr 11 17:50

Patrick Wood Reaffirms Buy Rating for RxSight Amid Strong Growth and Market Expansion Potential

TipRanksMar 5 03:05

RxSight Analyst Ratings

BenzingaFeb 29 23:49

Oppenheimer Adjusts RxSight Price Target to $61 From $54, Maintains Outperform Rating

MT NewswiresFeb 29 22:35

Oppenheimer Reaffirms Their Buy Rating on RxSight (RXST)

TipRanksFeb 29 21:06

Buy Rating on RxSight: Strong Financials and Positive 2024 Outlook Drive Upward Price Target

TipRanksFeb 29 19:26

Analysts Are Bullish on Top Healthcare Stocks: RxSight (RXST), Personalis (PSNL)

TipRanksFeb 29 18:20

RxSight (RXST) Gets a Buy From BTIG

TipRanksFeb 22 18:25

Analysts' Top Healthcare Picks: RxSight (RXST), Adaptive Biotechnologies (ADPT)

TipRanksFeb 20 19:20

RxSight Analyst Ratings

BenzingaFeb 12 22:43

RxSight Analyst Ratings

BenzingaJan 30 02:46

Oppenheimer Raises RxSight Price Target to $54 From $50, Maintains Outperform Rating

MT NewswiresJan 29 22:14

RxSight Analyst Ratings

BenzingaJan 16 23:31

Oppenheimer Raises RxSight Price Target to $50 From $46, Maintains Outperform Rating

MT NewswiresJan 16 22:39

RxSight Analyst Ratings

BenzingaJan 9 02:10

Oppenheimer Ups Price Target on RxSight to $46 From $38, Maintains Outperform Rating

MT NewswiresJan 8 22:25

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Ultragenyx Pharmaceutical (RARE) and Inspire Medical Systems (INSP)

TipRanksJan 8 21:00

RxSight (RXST) Initiated With a Buy at Stifel Nicolaus

TipRanksJan 8 20:46